Quick Answer
AMGEN INC reported Common Stock Shares Outstanding of 538.80 million shares for the year ending 2025.
- AMGEN INC showed an increase of +0.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from AMGEN INC's annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), AMGEN INC's Common Stock Shares Outstanding has declined by 48.5%.
- Historical annual values: Fiscal year 2025: 538.80 million shares | Fiscal year 2024: 536.90 million shares | Fiscal year 2023: 535.40 million shares | Fiscal year 2022: 534.00 million shares | Fiscal year 2021: 558.30 million shares | Fiscal year 2020: 578.30 million shares | Fiscal year 2019: 591.40 million shares | Fiscal year 2018: 629.60 million shares | Fiscal year 2017: 722.20 million shares | Fiscal year 2016: 738.20 million shares | Fiscal year 2015: 754.00 million shares | Fiscal year 2014: 760.40 million shares | Fiscal year 2013: 754.60 million shares | Fiscal year 2012: 756.30 million shares | Fiscal year 2011: 795.60 million shares | Fiscal year 2010: 932.10 million shares | Fiscal year 2009: 995.00 million shares | Fiscal year 2008: 1.05 billion shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: